Back to top

Image: Bigstock

Interpreting Dentsply (XRAY) International Revenue Trends

Read MoreHide Full Article

Have you evaluated the performance of Dentsply International's (XRAY - Free Report) international operations for the quarter ending June 2024? Given the extensive global presence of this dental products manufacturer, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.

In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For investors, the key is to grasp how reliant a company is on overseas markets, as this provides insights into the durability of its earnings, its ability to exploit different economic cycles, and its overall growth capabilities.

International market involvement serves as insurance against economic downturns at home and enables engagement with economies that are growing more quickly. Still, this move toward diversification is not without its challenges, as it involves navigating through the fluctuations of currencies, geopolitical threats, and the distinctive nature of various markets.

While analyzing XRAY's performance for the last quarter, we found some intriguing trends in revenues from its overseas segments that Wall Street analysts commonly model and monitor.

The company's total revenue for the quarter amounted to $984 million, showing decrease of 4.3%. We will now explore the breakdown of XRAY's overseas revenue to assess the impact of its international operations.

A Closer Look at XRAY's Revenue Streams Abroad

Europe generated $387 million in revenues for the company in the last quarter, constituting 39.3% of the total. This represented a surprise of -2.13% compared to the $395.44 million projected by Wall Street analysts. Comparatively, in the previous quarter, Europe accounted for $376 million (39.5%), and in the year-ago quarter, it contributed $403 million (39.2%) to the total revenue.

Of the total revenue, $237 million came from Rest of World during the last fiscal quarter, accounting for 24.1%. This represented a surprise of -0.2% as analysts had expected the region to contribute $237.47 million to the total revenue. In comparison, the region contributed $221 million, or 23.2%, and $263 million, or 25.6%, to total revenue in the previous and year-ago quarters, respectively.

International Revenue Predictions

For the current fiscal quarter, it is anticipated by Wall Street analysts that Dentsply will report a total revenue of $948.09 million, which reflects an increase of 0.1% from the same quarter in the previous year. The revenue contributions are expected to be 38% from Europe ($360.66 million) and 24.6% from Rest of World ($233.37 million).

For the full year, the company is expected to generate $3.89 billion in total revenue, down 1.8% from the previous year. Revenues from Europe and Rest of World are expected to constitute 39.4% ($1.53 billion) and 24.1% ($937.18 million) of the total, respectively.

Wrapping Up

Dentsply's leaning on foreign markets for its revenue stream presents a mix of chances and challenges. Therefore, a vigilant watch on its international revenue movements can greatly aid in projecting the company's future direction.

With the increasing intricacies of global interdependence and geopolitical strife, Wall Street analysts meticulously observe these patterns, especially for companies with an international footprint, to tweak their forecasts of earnings. Importantly, several additional factors, such as a company's domestic market status, also impact these earnings forecasts.

Emphasizing a company's shifting earnings prospects is a key aspect of our approach at Zacks, especially since research has proven its substantial influence on a stock's price in the short run. This correlation is positively aligned, meaning that improved earnings projections tend to boost the stock's price.

The Zacks Rank, our proprietary stock rating mechanism, demonstrates a notable performance history confirmed through external audits. It effectively utilizes the power of earnings estimate revisions to act as a predictor of a stock's price performance in the near term.

Dentsply currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Reviewing Dentsply's Recent Stock Price Trends

The stock has witnessed an increase of 3.8% over the past month versus the Zacks S&P 500 composite's a decrease of 2.9%. In the same interval, the Zacks Medical sector, to which Dentsply belongs, has registered an increase of 3.2%. Over the past three months, the company's shares saw a decrease of 8.6%, while the S&P 500 increased by 5.9%. In comparison, the sector experienced an increase of 5.1% during this timeframe.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


DENTSPLY SIRONA Inc. (XRAY) - free report >>

Published in